Viewing Study NCT02752685

Bugs

Ignite Creation Date: 2025-12-18 @ 8:40 AM

Ignite Modification Date: 2025-12-23 @ 9:50 PM

Study NCT ID: NCT02752685

Status:

Last Update Posted:

First Post:

Is Possible Gene Therapy: False

Has Adverse Events: False

Brief Title: Phase II Study of Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic Breast Cancer

Sponsor:

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Contacts Locations Module Design Module Eligibility Module Outcomes Module